Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study

被引：0
作者：
Yi Chen
Kai Chen
Xiaoyun Xiao
Yan Nie
Shaohua Qu
Chang Gong
Fengxi Su
Erwei Song
机构：
[1] Sun Yat-sen University,Department of Breast Tumor Center, Sun Yat
[2] Sun Yat-sen University,sen Memorial Hospital
[3] Sun Yat-sen University,Department of Ultrasound, Sun Yat
[4] Collaborative Innovation Center for Cancer Medicine,sen Memorial Hospital
来源：
BMC Cancer | / 16卷
关键词：
Breast cancer; Neutrophil to lymphocyte ratio; Pathologic complete response; RFS; BCSS; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study
    Chen, Yi
    Chen, Kai
    Xiao, Xiaoyun
    Nie, Yan
    Qu, Shaohua
    Gong, Chang
    Su, Fengxi
    Song, Erwei
    BMC CANCER, 2016, 16
  • [2] Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy Meta-analysis
    Xue, Ling Bo
    Liu, Yong Hong
    Zhang, Bo
    Yang, Yan Fang
    Yang, Dong
    Zhang, Li Wei
    Jin, Jian
    Li, Jie
    MEDICINE, 2019, 98 (01) : E13842
  • [3] The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Gao, Siming
    Tang, Wenjie
    Zuo, Bingli
    Mulvihill, Lianne
    Yu, Jinming
    Yu, Yishan
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [4] Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
    Ebaid, Naglaa F.
    Abdelkawy, Khaled S.
    Said, Amira S. A.
    Al-Ahmad, Mohamad M.
    Shehata, Mohamed A.
    Salem, Heba F.
    Hussein, Raghda R. S.
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [5] Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Ocana, Alberto
    Chacon, Jose Ignacio
    Calvo, Lourdes
    Anton, Antonio
    Mansutti, Mauro
    Albanell, Joan
    Martinez, Maria Teresa
    Lahuerta, Ainhara
    Bisagni, Giancarlo
    Bermejo, Begona
    Semiglazov, Vladimir
    Thill, Marc
    Chan, Arlene
    Morales, Serafin
    Herranz, Jesus
    Tusquets, Ignacio
    Chiesa, Massimo
    Caballero, Rosalia
    Valagussa, Pinuccia
    Bianchini, Giampaolo
    Alba, Emilio
    Gianni, Luca
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [6] The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?
    Ou, Qingqing
    Cheng, Jiang
    Zhang, Licui
    Wang, Huimin
    Wang, Wei
    Ma, Yajing
    TUMOR BIOLOGY, 2017, 39 (06) : 1 - 7
  • [7] Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: single center experience from Turkey
    Acikgoz, Ozgur
    Yildiz, Anil
    Bilici, Ahmet
    Olmez, Omer Fatih
    Basim, Pelin
    Cakir, Asli
    ANTI-CANCER DRUGS, 2022, 33 (10) : 1150 - 1155
  • [8] Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
    Marin Hernandez, C.
    Pinero Madrona, A.
    Gil Vazquez, P. J.
    Galindo Fernandez, P. J.
    Ruiz Merino, G.
    Alonso Romero, J. L.
    Parrilla Paricio, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (04) : 476 - 483
  • [9] Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
    C. Marín Hernández
    A. Piñero Madrona
    P. J. Gil Vázquez
    P. J. Galindo Fernández
    G. Ruiz Merino
    J. L. Alonso Romero
    P. Parrilla Paricio
    Clinical and Translational Oncology, 2018, 20 : 476 - 483
  • [10] Neutrophil-To-Lymphocyte Ratio as a Prognostic Indicator in Thyroid Cancer
    Gao, Qiangang
    Quan, Mingming
    Zhang, Lilong
    Ran, Yanyun
    Zhong, Jijun
    Wang, Bin
    CANCER CONTROL, 2024, 31
12345